In response to demand from pharma and biotech companies to accelerate leadtimes in drug discovery, Tripos, a provider of drug discovery chemistry, software and enterprise informatics to the industry, plans a major expansion of its existing facility in England’s Cornwall. The company announced this week that it will more than double its Receptor Research facility in Bude to 65,000 sq ft, and increase its workforce to 230 people by early 2004.
Tripos recently clinched a four-year, $100 million agreement with Pfizer to design, synthesise and purify high-quality, drug-like compounds to expand their high-throughput screening compound collection.
Tripos Receptor Research uses proprietary information-driven technologies to enhance the efficient design and synthesis of chemical compound libraries. These highly-focused LeadQuest(R) libraries are used around the world by other leading drug discovery companies such as Lipha S.A. (the French subsidiary of Merck KgA), to identify promising new drug candidates.
Tripos rescues stalled discovery projects and navigates around patented chemical space to quickly move discovery projects forward for its customers. Since 1999 Tripos Receptor Research has accelerated the early phases of drug discovery by a factor of two for its collaborators and customers, saving them significant time and costs in bringing new drugs to market; produced over 250,000 high-quality, novel compounds with drug-like
characteristics that can be used in the drug discovery process and successfully collaborated on discovery research projects, with four patents issued or in preparation;
Tripos will invest over £16 million in the new facility, with £3.7 million being funded through a combined grant from the British Government's Department of Trade and Industry's Regional Selective Assistance Program and the South West Regional Development Agency. The expanded facility will be one of the largest employers in the Cornwall area and will positively impact the local economy by creating a significant number of high-quality, highly-technical jobs in the region.
Tripos bought British specialty chemicals company Receptor Research Ltd. in 1997.
By October 2000, the new combined entity had won the Queen's Award for Enterprise for successive incremental increases in the export of chemical compounds to countries outside the United Kingdom.
Give your story premium visibility!